Bisphenol A and estradiol are equipotent in antagonizing cisplatin-induced cytotoxicity in breast cancer cells

Cancer Letters

Volumn 290, Issue 2, 2010, Pages 167-173

  LaPensee, Elizabeth W ^a   LaPensee, Christopher R ^a   Fox, Sejal ^a   Schwemberger, Sandy ^b   Afton, Scott ^b   Ben Jonathan, Nira ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Bcl 2; Bisphenol A; Breast cancer cells; Cisplatin; Estradiol; Estrogen receptors

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ANTINEOPLASTIC AGENT; CISPLATIN; ESTRADIOL; ESTROGEN RECEPTOR; PROTEIN BCL 2;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DRUG ANTAGONISM; HORMONE INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SEPARATION; CISPLATIN; DRUG RESISTANCE, NEOPLASM; ESTRADIOL; ESTROGENS; ESTROGENS, NON-STEROIDAL; FEMALE; FLOW CYTOMETRY; HUMANS; PHENOLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77649185059     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.09.005     Document Type: Article

References (36)

1. Wang D., and Lippard S.J. Cellular processing of platinum anticancer drugs. Nat. Rev. Drug Discov. 4 (2005) 307-320
2. Decatris M.P., Sundar S., and O'byrne K.J. Platinum-based chemotherapy in metastatic breast cancer: current status. Cancer Treat. Rev. 30 (2004) 53-81
3. Coley H.M. Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer. Cancer Treat. Rev. 34 (2008) 378-390
4. Igney F.H., and Krammer P.H. Death and anti-death: tumour resistance to apoptosis. Nat. Rev. Cancer 2 (2002) 277-288
5. Youle R.J., and Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 9 (2008) 47-59
6. Russo J., and Russo I.H. The role of estrogen in the initiation of breast cancer. J. Steroid Biochem. Mol. Biol. 102 (2006) 89-96
7. Platet N., Cathiard A.M., Gleizes M., and Garcia M. Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit. Rev. Oncol. Hematol. 51 (2004) 55-67
8. Jordan V.C., and Brodie A.M. Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer. Steroids 72 (2007) 7-25
9. Matthews J., and Gustafsson J.A. Estrogen signaling: a subtle balance between ER alpha and ER beta. Mol. Interv. 3 (2003) 281-292
10. Prossnitz E.R., Arterburn J.B., Smith H.O., Oprea T.I., Sklar L.A., and Hathaway H.J. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu. Rev. Physiol. 70 (2008) 165-190
11. Kyprianou N., English H.F., Davidson N.E., and Isaacs J.T. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res. 51 (1991) 162-166
12. Rodrik V., Zheng Y., Harrow F., Chen Y., and Foster D.A. Survival signals generated by estrogen and phospholipase D in MCF-7 breast cancer cells are dependent on Myc. Mol. Cell Biol. 25 (2005) 7917-7925
13. Huang Y., Ray S., Reed J.C., Ibrado A.M., Tang C., Nawabi A., and Bhalla K. Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells. Breast Cancer Res. Treat. 42 (1997) 73-81
14. Teixeira C., Reed J.C., and Pratt M.A. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res. 55 (1995) 3902-3907
15. Razandi M., Pedram A., and Levin E.R. Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer. Mol. Endocrinol. 14 (2000) 1434-1447
16. Welshons W.V., Nagel S.C., and Vom Saal F.S. Large effects from small exposures III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 147 (2006) S56-S69
17. Le H.H., Carlson E.M., Chua J.P., and Belcher S.M. Bisphenol A is released from polycarbonate drinking bottles and mimics the neurotoxic actions of estrogen in developing cerebellar neurons. Toxicol. Lett. 176 (2008) 149-156
18. Soto A.M., Vandenberg L.N., Maffini M.V., and Sonnenschein C. Does breast cancer start in the womb?. Basic Clin. Pharmacol. Toxicol. 102 (2008) 125-133
19. Prins G.S., Birch L., Tang W.Y., and Ho S.M. Developmental estrogen exposures predispose to prostate carcinogenesis with aging. Reprod. Toxicol. 23 (2007) 374-382
20. Soto A.M., Sonnenschein C., Chung K.L., Fernandez M.F., Olea N., and Serrano F.O. The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ. Health Perspect. 103 Suppl. 7 (1995) 113-122
21. Diel P., Olff S., Schmidt S., and Michna H. Effects of the environmental estrogens bisphenol A, o, p'-DDT, p-tert-octylphenol and coumestrol on apoptosis induction, cell proliferation and the expression of estrogen sensitive molecular parameters in the human breast cancer cell line MCF-7. J. Steroid Biochem. Mol. Biol. 80 (2002) 61-70
22. Singleton D.W., Feng Y., Yang J., Puga A., Lee A.V., and Khan S.A. Gene expression profiling reveals novel regulation by bisphenol-A in estrogen receptor-alpha-positive human cells. Environ. Res. 100 (2006) 86-92
23. Dairkee S.H., Seok J., Champion S., Sayeed A., Mindrinos M., Xiao W., Davis R.W., and Goodson W.H. Bisphenol A induces a profile of tumor aggressiveness in high-risk cells from breast cancer patients. Cancer Res. 68 (2008) 2076-2080
24. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., Van der Saag P.T., van der B.B., and Gustafsson J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139 (1998) 4252-4263
25. Thomas P., and Dong J. Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption. J. Steroid Biochem. Mol. Biol. 102 (2006) 175-179
26. Okada H., Tokunaga T., Liu X., Takayanagi S., Matsushima A., and Shimohigashi Y. Direct evidence revealing structural elements essential for the high binding ability of bisphenol A to human estrogen-related receptor-gamma. Environ. Health Perspect. 116 (2008) 32-38
27. Lapensee E.W., Tuttle T.R., Fox S.R., and Ben-Jonathan N. Bisphenol A at low nanomolar doses confers chemoresistance in estrogen receptor-alpha-positive and -negative breast cancer cells. Environ. Health Perspect. 117 (2009) 175-180
28. Hugo E.R., Brandebourg T.D., Comstock C.E., Gersin K.S., Sussman J.J., and Ben Jonathan N. LS14: a novel human adipocyte cell line that produces prolactin. Endocrinology 147 (2006) 306-313
29. Sui M., Huang Y., Park B.H., Davidson N.E., and Fan W. Estrogen receptor alpha mediates breast cancer cell resistance to paclitaxel through inhibition of apoptotic cell death. Cancer Res. 67 (2007) 5337-5344
30. Russo J., Fernandez S.V., Russo P.A., Fernbaugh R., Sheriff F.S., Lareef H.M., Garber J., and Russo I.H. 17-Beta-estradiol induces transformation and tumorigenesis in human breast epithelial cells. FASEB J. 20 (2006) 1622-1634
31. Olsen C.M., Meussen-Elholm E.T., Samuelsen M., Holme J.A., and Hongslo J.K. Effects of the environmental oestrogens bisphenol A, tetrachlorobisphenol A, tetrabromobisphenol A, 4-hydroxybiphenyl and 4, 4'-dihydroxybiphenyl on oestrogen receptor binding, cell proliferation and regulation of oestrogen sensitive proteins in the human breast cancer cell line MCF-7. Pharmacol. Toxicol. 92 (2003) 180-188
32. Hugo E.R., Brandebourg T.D., Woo J.G., Loftus J., Alexander J.W., and Ben-Jonathan N. Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environ. Health Perspect. 116 (2008) 1642-1647
33. Samuelsen M., Olsen C., Holme J.A., Meussen-Elholm E., Bergmann A., and Hongslo J.K. Estrogen-like properties of brominated analogs of bisphenol A in the MCF-7 human breast cancer cell line. Cell Biol. Toxicol. 17 (2001) 139-151
34. Filardo E.J., Quinn J.A., Bland K.I., and Frackelton Jr. A.R. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol. Endocrinol. 14 (2000) 1649-1660
35. Matsushima A., Kakuta Y., Teramoto T., Koshiba T., Liu X., Okada H., Tokunaga T., Kawabata S., Kimura M., and Shimohigashi Y. Structural evidence for endocrine disruptor bisphenol A binding to human nuclear receptor ERR gamma. J. Biochem. 142 (2007) 517-524
36. Siddik Z.H. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22 (2003) 7265-7279